CSL Behring

Focus: We offer a wide range of recombinant and plasma-derived medicines, treating rare and serious conditions like chronic inflammatory demyelinating polyneuropathy.

A biotechnology company involved for more than a century with research and development related to severe and rare diseases, giving our support to patients with severe diseases.

Pharmaceutical Companies